Eplerenone Combination Versus Conventional Agents to Lower Blood Pressure on Urinary Antialbuminuric Treatment Effect Trial.

Trial Profile

Eplerenone Combination Versus Conventional Agents to Lower Blood Pressure on Urinary Antialbuminuric Treatment Effect Trial.

Completed
Phase of Trial: Phase III

Latest Information Update: 12 May 2016

At a glance

  • Drugs Eplerenone (Primary)
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Acronyms EVALUATE
  • Most Recent Events

    • 15 Jun 2015 Results assessing dietary salt intake presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.
    • 14 May 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 14 Jun 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top